Prenatal And Newborn Genetic Testing Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Prenatal And Newborn Genetic Testing Market Growth in 2025?
The market size of prenatal and newborn genetic testing has seen a fast-paced growth in the past few years. Its growth from $6.68 billion in 2024 to $7.61 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%, reflects this upward trend. The factors that have contributed to the growth during the historical period include enhanced non-invasive prenatal testing, a rise in maternal age, governmental assistance and health care regulations, along with patient preferances for early diagnosis.
What Is the Forecast for the Prenatal And Newborn Genetic Testing Market Size Through 2029?
The market size of prenatal and newborn genetic testing is projected to witness accelerated expansion in the forthcoming years. By 2029, it is anticipated to reach $12.04 billion, with a compound annual growth rate (CAGR) of 12.1%. This growth is expected to be driven by factors such as the enhancement of genetic test panels, increased awareness about maternal health, guidelines for prenatal and newborn screening, a heightened focus on uncommon diseases, and ethical and regulatory considerations. Noteworthy trends throughout this forecast period are likely to include non-invasive prenatal testing (NIPT), whole genome sequencing (WGS) and whole exome sequencing, artificial intelligence (AI) integration, preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
What are the Key Market Players in Prenatal And Newborn Genetic Testing Market and How They’re Evolving?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.
What Are the Primary Growth Drivers in the Prenatal And Newborn Genetic Testing Market?
The expansion of the prenatal and newborn genetic testing markets is likely to be driven by government initiatives and support for prenatal testing and newborn genetic screening. Such initiatives from the government can come in the form of particular actions, programs, projects, or policies, aimed at tackling certain issues, achieving defined goals, or improving citizens’ wellbeing. These initiatives, specifically focused on prenatal and newborn genetic testing, help the populace by detecting genetic abnormalities in fetuses during pregnancy, or in newborns shortly after they’re born. For example, in June 2022, the government of Australia committed an annual $1.3 million to the newborn screening program in New South Wales (NSW), a state on Australia’s east coast. The program provides free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), including the newborn genetic testing and screening, to every newborn in the state. With the capacity to provide screening tests to approximately 100,000 babies per year, this program can potentially save up to 13 newborns likely to have these genetic disorders. The growth of the prenatal and newborn genetic testing markets is thus facilitated by government initiatives and support for these kinds of testing and screening.
Prenatal And Newborn Genetic Testing Market Driver: Surge in Genetic Disorder Rates Spurs Prenatal And Newborn Genetic Testing Market Growth
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp
What Are the Leading Segments in the Global Prenatal And Newborn Genetic Testing Industry?
The prenatal and newborn genetic testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers
What Are the Key Market Trends in the Prenatal And Newborn Genetic Testing Industry?
Principal businesses in the prenatal and newborn genetic testing arena are concentrating their efforts on launching innovative screening tests, such as noninvasive prenatal screening tests. They are aiming to improve both accessibility and affordability, ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) is an advanced and secure genetic screening approach used during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. For instance, in November 2022, Juno Diagnostics Inc., a healthcare technology firm based in the United States, unveiled Juno Hazel. This is a noninvasive prenatal screening test designed to identify chromosomal deviations and offer clinical context. By leveraging a sample collection kit, the test eliminates the requirement for phlebotomy and enhances accessibility. Furthermore, the company intends to provide educational materials and individualized genetic counseling support through collaborations with physicians and genetic counselors.
Access The Full Report Here:
What Is the Regional Outlook for the Prenatal And Newborn Genetic Testing Market?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158
This Report Delivers Insight On:
1. How big is the prenatal and newborn genetic testing market, and how is it changing globally?
2. Who are the major companies in the prenatal and newborn genetic testing market, and how are they performing?
3. What are the key opportunities and risks in the prenatal and newborn genetic testing market right now?
4. Which products or customer segments are growing the most in the prenatal and newborn genetic testing market?
5. What factors are helping or slowing down the growth of the prenatal and newborn genetic testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
